BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3132441)

  • 1. Imipenem/cilastatin, an alternative treatment of pseudomonas infection in cystic fibrosis.
    Strandvik B; Malmborg AS; Bergan T; Michalsen H; Storrøsten OT; Wretlind B
    J Antimicrob Chemother; 1988 Apr; 21(4):471-80. PubMed ID: 3132441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS; Pressler T; Jensen T; Rosdahl VT; Bentzon MW; Høiby N; Koch C
    J Antimicrob Chemother; 1987 Jan; 19(1):101-7. PubMed ID: 3104273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipenem/cilastatin treatment of multiresistant Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Pedersen SS; Pressler T; Høiby N; Bentzon MW; Koch C
    J Antimicrob Chemother; 1985 Nov; 16(5):629-35. PubMed ID: 3935639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipenem/cilastatin in acute pulmonary exacerbations of cystic fibrosis.
    Krilov LR; Blumer JL; Stern RC; Hartstein AI; Iglewski BN; Goldmann DA
    Rev Infect Dis; 1985; 7 Suppl 3():S482-9. PubMed ID: 3901211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of resistance in imipenem therapy in Pseudomonas aeruginosa].
    Krech T; Naumann P
    Immun Infekt; 1986 Nov; 14(6):224-6. PubMed ID: 3100426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of bronchopulmonary infections in patients during artificial respiration with imipenem/cilastatin].
    Unertl K; Lenhart FP; Ruckdeschel G
    Immun Infekt; 1986 Nov; 14(6):229-31. PubMed ID: 3100428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and clinical evaluation of imipenem/cilastatin in children and neonates.
    Bégué PC; Baron S; Challier P; Fontaine JL; Lasfargues G
    Scand J Infect Dis Suppl; 1987; 52():40-5. PubMed ID: 3483288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem: a new carbapenem antibiotic.
    Lipman B; Neu HC
    Med Clin North Am; 1988 May; 72(3):567-79. PubMed ID: 3280907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience.
    Acar JF
    Rev Infect Dis; 1985; 7 Suppl 3():S513-7. PubMed ID: 3931199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of respiratory tract infections with imipenem/cilastatin in critical patients with respiratory insufficiency].
    Unertl K; Ruckdeschel G; Forst H; Lenhart FP
    Infection; 1986; 14 Suppl 2():S176-80. PubMed ID: 3759253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with imipenem/cilastatin in the treatment of severe infections in general surgery].
    Mayer M; Brand J; Schlenkhoff D; Opferkuch W
    Infection; 1986; 14 Suppl 2():S160-3. PubMed ID: 3079549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primaxin in the treatment of acute bacterial pneumonia in adults.
    Gebhart RJ; Duma RJ; Patterson PM; Bagett JW; Williams DS
    J Antimicrob Chemother; 1985 Feb; 15(2):233-8. PubMed ID: 3980311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of imipenem/cilastatin in severely burned and infected patients.
    Culbertson GR; McManus AT; Conarro PA; McManus WF; Mason AD; Pruitt BA
    Surg Gynecol Obstet; 1987 Jul; 165(1):25-8. PubMed ID: 3109046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative clinical trial of imipenem-cilastatin (N-formimidoyl-thienamycin-dehydropeptidase inhibitor) and cefazolin.
    Marier RL; McCloskey RV; Dickenson G; Sanders CV; Aldridge KE; Hoffman T; Gutterman D; Janney A
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():133-9. PubMed ID: 6365873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
    Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and tolerance of imipenem/cilastatin in the treatment of surgical infections with and without bone involvement].
    Voeckl J; Fischer M
    Infection; 1986; 14 Suppl 2():S154-9. PubMed ID: 3759250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of imipenem: the first thienamycin antibiotic.
    Kropp H; Gerckens L; Sundelof JG; Kahan FM
    Rev Infect Dis; 1985; 7 Suppl 3():S389-410. PubMed ID: 3931196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
    Pastel DA
    Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipenem/cilastatin for the treatment of infections in hospitalized children.
    Alpert G; Dagan R; Connor E; Campos JM; Bloh AM; Powell KR; Plotkin SA
    Am J Dis Child; 1985 Nov; 139(11):1153-6. PubMed ID: 3904406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.